Candesartan attenuates ischemic brain edema and protects the blood-brain barrier integrity from ischemia/reperfusion injury in rats

Iranian Biomedical Journal

Volumn 18, Issue 4, 2014, Pages 232-238

  Panahpour, Hamdollah ^a   Nekooeian, Ali Akbar ^b   Dehghani, Gholam Abbas ^b  

^a ARDABIL UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

AT1 receptor; Blood brain barrier; Brain edema; Candesartan

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; CANDESARTAN; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; BENZIMIDAZOLE DERIVATIVE; TETRAZOLE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; BRAIN EDEMA; BRAIN INFARCTION SIZE; BRAIN ISCHEMIA; CONTROLLED STUDY; DRUG MECHANISM; DRUG RESPONSE; MALE; MEAN ARTERIAL PRESSURE; NEUROLOGICAL DYSFUNCTION SCORE; NEUROPROTECTION; NONHUMAN; RAT; REPERFUSION INJURY; SCORING SYSTEM; ANIMAL; BRAIN; BRAIN INJURIES; CEREBRAL ARTERY DISEASE; COMPLICATION; DRUG EFFECTS; PATHOLOGY; PATHOPHYSIOLOGY; SPRAGUE DAWLEY RAT;

ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANIMALS; BENZIMIDAZOLES; BLOOD-BRAIN BARRIER; BRAIN; BRAIN EDEMA; BRAIN INJURIES; BRAIN ISCHEMIA; INFARCTION, MIDDLE CEREBRAL ARTERY; MALE; RATS; RATS, SPRAGUE-DAWLEY; REPERFUSION INJURY; TETRAZOLES;

EID: 84906043404     PISSN: 1028852X     EISSN: None     Source Type: Journal    
DOI: 10.6091/ibj.13672.2014     Document Type: Article

References (34)

1. Zhang TL, Fu JL, Geng Z, Yang JJ, Sun XJ. The neuroprotective effect of losartan through inhibiting AT1/ASK1/MKK4/JNK3 pathway following cerebral I/R in rat hippocampal CA1 region. CNS Neurosci Ther. 2012 Dec;18(12):981-87.
2. Takemori K, Inoue T, Ito H. Effects of angiotensin II type 1 receptor blocker and adiponectin on adipocyte dysfunction in stroke-prone spontaneously hypertensive rats. Lipids Health Dis. 2013 Jul; 12:1-6.
3. Saad MA, Abbas AM, Boshra V, Elkhateeb M, El Aal IA. Effect of angiotensin II type 1 receptor blocker, candesartan, and beta 1 adrenoceptor blocker, atenolol, on brain damage in ischemic stroke. Acta Physiol Hung. 2010 Jun; 97(2):159-71.
4. Panahpour H, Dehghani GA. Attenuation of focal cerebral ischemic injury following post-ischemic inhibition of angiotensin converting enzyme (ACE) activity in normotensive rat. Iran Biomed J. 2012;16(4):202-8.
5. Panahpour H, Dehghani GA. Inhibition of central angiotensin- converting enzyme with enalapril protects the brain from ischemia/reperfusion injury in normotensive rat. Daru. 2010; 18(1):35-40.
6. Zhou J, Pavel J, Macova M, Yu ZX, Imboden H, Ge L, et al., AT1 receptor blockade regulates the local angiotensin II system in cerebral microvessels from spontaneously hypertensive rats. Stroke. 2006 May; 37(5):1271-76.
7. Lan R, Xiang J, Wang GH, Li WW, Zhang W, Xu LL, et al. Xiao-Xu-Ming Decoction Protects against Blood- Brain Barrier Disruption and Neurological Injury Induced by Cerebral Ischemia and Reperfusion in Rats. Evid Based Complement Alternat Med. 2013 April; 2013:1-12.
8. Marmarou A. A review of progress in understanding the pathophysiology and treatment of brain edema. Neurosurg Focus. 2007 May; 22(5):1-10.
9. Xu M, Su W, Xu QP. Aquaporin-4 and traumatic brain edema. Chin J Traumatol. 2010 Apr; 13(2):103-10.
10. Gu Y, Dee CM, Shen J. Interaction of free radicals, matrix metalloproteinases and caveolin-1 impacts bloodbrain barrier permeability. Front Biosci (Schol Ed). 2011 Jun; 3:1216-31.
11. Rosenberg GA, Yang Y. Vasogenic edema due to tight junction disruption by matrix metalloproteinases in cerebral ischemia. Neurosurg Focus. 2007 May; 22(5):1-9.
12. Zhou F, Xiang Z, Feng WX, Zhen LX. Neuronal free Ca2+ and BBB permeability and ultrastructure in head injury with secondary insult. J Clin Neuroscience. 2001 Nov; 8 (6):561-63.
13. Blezer EL, Nicolay K, Koomans HA, Joles JA. Losartan versus enalapril on cerebral edema and proteinuria in stroke-prone hypertensive rats. Am J Hypertens. 2001 Jan; 14(1):54-61.
14. Ito T, Yamakawa H, Bregonzio C, Terron JA, Falcon- Neri A, Saavedra JM. Protection against ischemia and improvement of cerebral blood flow in genetically hypertensive rats by chronic pretreatment with an angiotensin II AT1 antagonist. Stroke. 2002 Sep; 33(9):2297-303.
15. Vakili, A, Nekooeian AA, and Dehghani GA. L-NAME and 7-Nitroindazole reduces brain injuries in transient focal cerebral ischemia in rat. Iran J Med Sci. 2004; 29(3):109-115.
16. Swanson RA, Morton MT, Tsao-Wu G, Savalos RA, Davidson C, Sharp FR., A semiautomated method for measuring brain infarct volume. J Cereb Blood Flow Metab. 1990 Mar; 10(2):290-93.
17. Panahpour, H., A.A. Nekooeian, and G.A. Dehghani, Inhibition of angiotensin-converting enzyme reduces cerebral infarction size in experimental-induced focal cerebral ischemia in the rat. Iran J Med Sci. 2007 Mar; 32(1):12-17.
18. Kaya M, Kucuk M, Kalayci R, Cimen V, Gurses C, Elmas I, et al. Magnesium sulfate attenuates increased blood-brain barrier permeability during insulin-induced hypoglycemia in rats. Can J Physiol Pharmacol. 2001 Sep; 79(9):793-98.
19. Nishimura Y, Ito T, Saavedra JM. Angiotensin II AT1 blockade normalizes cerebrovascular autoregulation and reduces cerebral ischemia in spontaneously hypertensive rats. Stroke. 2000 Oct; 31(10):2478-86.
20. Brdon J, Kaiser S, Hagemann F, Zhao Y, Culman J, Gohlke P. Comparison between early and delayed systemic treatment with candesartan of rats after ischaemic stroke. J Hypertens.2007 Jan; 25(1):187-96.
21. Asiedu-Gyekye IJ, Antwi DA. Does losartan prevent cerebral edema? A preliminary study using a vascular compartment model. Med Sci Monit. 2003 Mar; 9(3):BR127-30.
22. Hosomi N, Mizushige K, Kitadai M, Ohyama H, Ichihara SI, Takahashi T, et al. Induced hypertension treatment to improve cerebral ischemic injury after transient forebrain ischemia. Brain Res. 1999 Jul; 835(2):188-96.
23. Bennai F, Morsing P, Paliege A, Ketteler M, Mayer B, Tapp R, et al. Normalizing the expression of nitric oxide synthase by low-dose AT1 receptor antagonism parallels improved vascular morphology in hypertensive rats. J Am Soc Nephrol. 1999 Jan; 10(11):S104-15.
24. Vacher E, Richer C, Giudicelli JF. Effects of losartan on cerebral arteries in stroke-prone spontaneously hypertensive rats. J Hypertens. 1996 Nov; 14(11):1341-48.
25. Pueyo ME, Arnal JF, Rami J, Michel JB. Angiotensin II stimulates the production of NO and peroxynitrite in endothelial cells. Am J Physiol. 1998 Jan; 274(1):C214-20.
26. Wei EP, Ellison MD, Kontos HA, Povlishock JT. O2 radicals in arachidonate-induced increased blood-brain barrier permeability to proteins. Am J Physiol. 1986 Oct; 251(4):H693-99.
27. Hosomi N, Nishiyama A, Ban CR, Naya T, Takahashi T, Kohno M, Koziol JA. Angiotensin type1 receptor blockage improves ischemic injury following transient focal cerebral ischemia. Neuroscience. 2005; 134(1):225-31.
28. Kucuk M, Kaya M, Kalayci R, Cimen V, Kudat H, Arican N, et al. Effects of losartan on the blood-brain barrier permeability in long-term nitric oxide blockadeinduced hypertensive rats. Life Sci. 2002 Jul; 71(8):937-46.
29. Awad AS. Role of AT1 receptors in permeability of the blood-brain barrier in diabetic hypertensive rats. Vascul Pharmacol. 2006 Sep; 45(3):141-47.
30. Chan PH, Schmidley JW, Fishman RA, Longar SM. Brain injury, edema, and vascular permeability changes induced by oxygen-derived free radicals. Neurology. 1984 Mar; 34(3):315-20.
31. Mayhan WG, Didion SP. Glutamate-induced disruption of the blood-brain barrier in rats. Role of nitric oxide. Stroke. 1996 May; 27(5): 965-69.
32. Mun-Bryce S, Rosenberg GA. Matrix metalloproteinases in cerebrovascular disease. J Cereb Blood Flow Metab. 1998 Nov; 18(11):1163-72.
33. Awad AS. Effect of combined treatment with curcumin and candesartan on ischemic brain damage in mice. J Stroke Cerebrovasc Dis. 2011 Nov; 20(6):541-48.
34. Griendling KK, Ushio-Fukai M. NADH/NADPH oxidase and vascular function. Trends Cardiovasc Med. 1997 Nov; 7(8):301-7.